HPCSMN:一种基于多式联网的低喉癌化疗敏感性的分类方法
Weiqi Fu1, Haiyan Li2, Xiongwen Quan3
1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Engineering Research Center of Trusted Behavior Intelligence, Ministry of Education, College of Artificial Intelligence, Nankai University, Tianjin, 300350, China.
Interdisciplinary sciences, computational life sciences
|November 18, 2025
概括
这项研究引入了一个集成3DCT扫描和放射性特征的深度学习模型,以预测下腺癌中的化疗敏感性,提高个性化治疗的准确性.
科学领域:
- 在瘤学瘤学.
- 医疗成像医学成像
- 人工智能的人工智能
背景情况:
- 精确预测化疗敏感性对于个性化治疗下喉癌至关重要.
- 目前的方法在有效利用多式联运数据进行预测方面面临挑战.
研究的目的:
- 开发和验证基于深度学习的多式联络融合网络,用于对下癌的化疗敏感性进行分类.
- 通过整合3D CT成像和放射性特征来提高预测准确性.
主要方法:
- 设计了一个多式融合网络,包括3D ResNet用于从3D CT图像中提取空间特征,以及用于放射性特征的完全连接层.
- 使用LASSO回归选了放射性特征.
- 用完全连接的层融合特征向量以捕捉复杂的依赖关系.
主要成果:
- 多式联接网络在NKU-TMU-hphc数据集 (102个案例) 上对化疗敏感性进行分类时取得了高准确性.
- 拟议的模型在多个评估指标上表现优于单一模式方法和其他比较模型.
- 统计分析证实了成像和临床数据的有效整合.
结论:
- 开发的多式融合网络提供了一种新且有效的方法,用于在下喉癌中进行化疗敏感性分类.
- 这种方法有望改善头部和部瘤学的个性化医疗策略.
- 整合不同的数据模式可以显著提高预测性能.
更多相关视频
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K